Find Articles in:
All
Business
Reference
Technology
News
Lifestyle

Business Services Industry

eResearch Resumes Coverage on IRI Separation Technologies Inc.

Canadian Corporate News, March, 2008

TORONTO, ONTARIO, Mar 31, 2008 (Marketwire via COMTEX) -- IRI is a Vancouver-based biotechnology company that has developed a proprietary method for extracting proteins, known as immunoglobulin (antibodies), from liquids such as egg yolk. The Company's process results in higher quantities and greater purity levels at a cost cheaper than conventional processes.

eResearch has resumed coverage of IRI Separation Technologies Inc. with a Speculative Buy rating and a 12-month Target Price of $0.45 per share.

IRI is poised for the Phase 1 launch of its nutraceutical product (a food ...

 

BNET TalkbackShare your ideas and expertise on this topic

The following tags are supported in BNET comments:
<b></b> <i></i> <u></u> <pre></pre>

Leave a Reply

  1. You are currently a guest | Login?
advertisement
Go
advertisement
  • Click Here
  • Click Here
advertisement